10:32 AM EST, 11/10/2025 (MT Newswires) -- Armata Pharmaceuticals ( ARMP ) said Monday its Good Manufacturing Practice manufacturing facility in Los Angeles, California, has been commissioned.

The company said it has notified the US Food and Drug Administration that production has started, and production runs have been completed with no issues.

The plant allows Armata to make its multi-phage cocktails to support clinical trials, the company said.

Price: 5.92, Change: +0.14, Percent Change: +2.42